Published in J Cell Biol on April 01, 1995
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol (2003) 4.71
Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A (1998) 4.49
Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol (1998) 4.35
Cholesterol, lipid rafts, and disease. J Clin Invest (2002) 4.05
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A (2001) 3.39
Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J (1998) 3.22
Prions. Cold Spring Harb Perspect Biol (2011) 3.17
Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem (2009) 2.80
Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A (1996) 2.79
The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function. Pigment Cell Res (2005) 2.71
Cholesterol-dependent retention of GPI-anchored proteins in endosomes. EMBO J (1998) 2.63
Cultured cell sublines highly susceptible to prion infection. J Virol (2000) 2.38
Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J (2002) 2.16
Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J Cell Biol (2003) 2.12
Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A (1996) 2.12
New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol (2003) 2.09
A pore-forming toxin interacts with a GPI-anchored protein and causes vacuolation of the endoplasmic reticulum. J Cell Biol (1998) 2.04
COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci U S A (1997) 1.89
Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J (1996) 1.81
Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A (2003) 1.74
Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A (1999) 1.73
Species-dependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry (2010) 1.68
Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J (2001) 1.68
The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J (2003) 1.62
Identification of an intracellular site of prion conversion. PLoS Pathog (2009) 1.61
Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci (2000) 1.57
Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein. J Virol (2000) 1.52
Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol (2003) 1.51
The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J (2007) 1.50
Cellular biology of prion diseases. Clin Microbiol Rev (1999) 1.48
Traffic, polarity, and detergent solubility of a glycosylphosphatidylinositol-anchored protein after LDL-deprivation of MDCK cells. J Cell Biol (1996) 1.39
Propagation of prion strains through specific conformers of the prion protein. J Virol (1997) 1.35
GPI anchoring leads to sphingolipid-dependent retention of endocytosed proteins in the recycling endosomal compartment. EMBO J (2001) 1.31
Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J (2001) 1.29
Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner. J Virol (2007) 1.26
Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci U S A (2007) 1.25
Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun (2005) 1.22
Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J Virol (2000) 1.22
Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol Biol Cell (1999) 1.20
Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem (2009) 1.19
Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J (2008) 1.18
Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J (2001) 1.17
Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. J Virol (1997) 1.14
Retrotranslocation of prion proteins from the endoplasmic reticulum by preventing GPI signal transamidation. Mol Biol Cell (2008) 1.12
Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry (2010) 1.11
The intriguing prion disorders. Cell Mol Life Sci (2006) 1.09
Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins. Mol Biol Cell (2008) 1.08
Cells expressing anchorless prion protein are resistant to scrapie infection. J Virol (2009) 1.07
A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J Biol Chem (2011) 1.07
PrP(C) association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol Biol Cell (2004) 1.07
Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis. PLoS One (2008) 1.07
Elastic membrane heterogeneity of living cells revealed by stiff nanoscale membrane domains. Biophys J (2007) 1.05
Strain-specific role of RNAs in prion replication. J Virol (2012) 1.04
Glypican-1 mediates both prion protein lipid raft association and disease isoform formation. PLoS Pathog (2009) 1.04
Prion replication alters the distribution of synaptophysin and caveolin 1 in neuronal lipid rafts. Am J Pathol (2004) 1.04
The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment. Proc Natl Acad Sci U S A (2003) 1.03
Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J (2003) 1.03
Membrane topology influences N-glycosylation of the prion protein. EMBO J (2001) 1.03
Recent advances in prion chemotherapeutics. Infect Disord Drug Targets (2009) 1.03
Strain-associated variations in abnormal PrP trafficking of sheep scrapie. Brain Pathol (2008) 1.02
Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells. J Virol (2004) 0.99
Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform. J Virol (2001) 0.98
Cellular aspects of prion replication in vitro. Viruses (2013) 0.95
Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins. J Biol Chem (2012) 0.95
PrP(106-126) does not interact with membranes under physiological conditions. Biophys J (2008) 0.95
Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J Biol Chem (2011) 0.94
Neuronal low-density lipoprotein receptor-related protein 1 binds and endocytoses prion fibrils via receptor cluster 4. J Cell Sci (2010) 0.94
Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice. Proc Natl Acad Sci U S A (2007) 0.94
Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A (2006) 0.93
Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation. Cell Mol Life Sci (2009) 0.92
Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells. J Biol Chem (2009) 0.92
Identifying key components of the PrPC-PrPSc replicative interface. J Biol Chem (2008) 0.91
Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. J Lipid Res (2013) 0.91
Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles. PLoS One (2009) 0.91
Endocytosis of glycosylphosphatidylinositol-anchored proteins. J Biomed Sci (2009) 0.91
Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues. Biophys J (2004) 0.90
Recruitment of cellular prion protein to mitochondrial raft-like microdomains contributes to apoptosis execution. Mol Biol Cell (2011) 0.90
Cyclodextrins inhibit replication of scrapie prion protein in cell culture. J Virol (2007) 0.89
The spatial dynamics of prion disease. Proc Biol Sci (1998) 0.89
Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation. J Biol Chem (2011) 0.89
Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation. Biochemistry (2007) 0.89
The role of lipid rafts in cancer cell adhesion and migration. Int J Cell Biol (2011) 0.89
Proteolytic processing of the prion protein in health and disease. Am J Neurodegener Dis (2012) 0.88
Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells. PLoS One (2009) 0.88
Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. J Virol (2010) 0.88
Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation. J Biol Chem (2015) 0.88
Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs. J Cell Biol (2014) 0.88
Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int J Alzheimers Dis (2011) 0.87
Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation. J Biol Chem (2010) 0.87
A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets. J Biol Chem (2011) 0.86
Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Antimicrob Agents Chemother (2007) 0.86
N-terminally tagged prion protein supports prion propagation in transgenic mice. Protein Sci (1997) 0.85
Cellular prion protein: from physiology to pathology. Viruses (2012) 0.85
Differential effects of glycosphingolipids on the detergent-insolubility of the glycosylphosphatidylinositol-anchored membrane dipeptidase. Biochem J (2001) 0.85
The role of the prion protein membrane anchor in prion infection. Prion (2009) 0.84
Prion infection of epithelial Rov cells is a polarized event. J Virol (2004) 0.84
Separate mechanisms act concurrently to shed and release the prion protein from the cell. Prion (2012) 0.84
Copper binding to the PrP isoforms: a putative marker of their conformation and function. J Virol (2001) 0.83
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell (1992) 17.81
Mice devoid of PrP are resistant to scrapie. Cell (1993) 11.46
Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol (1983) 10.95
Molecular biology of prion diseases. Science (1991) 10.83
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Lipid sorting in epithelial cells. Biochemistry (1988) 7.64
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell (1990) 6.17
Cell-free formation of protease-resistant prion protein. Nature (1994) 6.07
Fluorescence microscopy: reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate. Science (1982) 5.92
Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell (1987) 5.12
Potocytosis: sequestration and transport of small molecules by caveolae. Science (1992) 4.94
Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A (1986) 4.38
Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol (1990) 4.37
Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science (1994) 4.36
The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23
The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. J Cell Biol (1990) 3.96
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci U S A (1993) 3.56
N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol (1991) 3.55
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54
Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci U S A (1993) 3.53
Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol (1990) 3.46
Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol (1988) 3.37
Distinct prion proteins in short and long scrapie incubation period mice. Cell (1987) 3.21
Distinct transport vesicles mediate the delivery of plasma membrane proteins to the apical and basolateral domains of MDCK cells. J Cell Biol (1990) 3.05
The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J Immunol (1992) 3.05
Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell (1993) 2.93
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology (1990) 2.90
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A (1994) 2.70
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem (1992) 2.67
Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci (1992) 2.67
Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci U S A (1992) 2.64
The picomole determination of free and total cholesterol in cells in culture. J Lipid Res (1978) 2.61
Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem (1993) 2.59
Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci U S A (1994) 2.38
Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J Cell Biol (1992) 2.30
Each caveola contains multiple glycosyl-phosphatidylinositol-anchored membrane proteins. Cold Spring Harb Symp Quant Biol (1992) 2.20
Detergent insolubility of alkaline phosphatase during biosynthetic transport and endocytosis. Role of cholesterol. J Biol Chem (1993) 2.14
Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14
Monoclonal antibodies to the cellular and scrapie prion proteins. J Infect Dis (1986) 2.13
Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13
Endocytosis of glycophospholipid-anchored and transmembrane forms of CD4 by different endocytic pathways. EMBO J (1992) 2.09
Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol (1989) 2.08
Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys (1989) 1.96
Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc Natl Acad Sci U S A (1993) 1.87
Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system. J Immunol (1991) 1.87
Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci (1992) 1.85
A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol (1994) 1.74
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J (1991) 1.74
Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform. Proc Natl Acad Sci U S A (1993) 1.65
Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci U S A (1990) 1.59
Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun (1993) 1.43
Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry (1993) 1.42
Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci U S A (1992) 1.38
Characterization of prion proteins with monospecific antisera to synthetic peptides. J Immunol (1988) 1.34
A prion-like protein from chicken brain copurifies with an acetylcholine receptor-inducing activity. Proc Natl Acad Sci U S A (1991) 1.24
Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems. J Virol (1992) 1.09
Purification and characterization of pig kidney aminopeptidase P. A glycosyl-phosphatidylinositol-anchored ectoenzyme. Biochem J (1990) 1.05
Carboxypeptidase M in Madin-Darby canine kidney cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor. J Biol Chem (1990) 0.98
Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate proteoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic, and intracellular degradative pathways. J Biol Chem (1992) 0.93
Obligatory relationship between the sterol biosynthetic pathway and DNA synthesis and cellular proliferation in glial primary cultures. J Neurochem (1986) 0.86
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature (1992) 9.01
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
Identification of a protein that purifies with the scrapie prion. Science (1982) 7.00
A protease-resistant protein is a structural component of the scrapie prion. Cell (1983) 6.72
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI. Neurology (2006) 6.66
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell (1990) 6.17
Purification and structural studies of a major scrapie prion protein. Cell (1984) 5.98
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell (1995) 5.16
Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell (1987) 5.12
Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest (1987) 4.98
Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell (1986) 4.82
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell (1989) 4.73
Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature (1989) 4.69
Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A (1986) 4.38
Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science (1990) 4.19
Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A (1997) 4.10
Further purification and characterization of scrapie prions. Biochemistry (1982) 4.01
Information access. Building a "GenBank" of the published literature. Science (2001) 3.95
Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A (1997) 3.78
A transmembrane form of the prion protein in neurodegenerative disease. Science (1998) 3.76
Linkage of prion protein and scrapie incubation time genes. Cell (1986) 3.69
Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol (1982) 3.68
Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A (1992) 3.68
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54
Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol (1990) 3.46
Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. Genome Res (1998) 3.44
Structural clues to prion replication. Science (1994) 3.43
Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A (1999) 3.43
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A (2001) 3.39
Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol (1988) 3.37
Distinct prion proteins in short and long scrapie incubation period mice. Cell (1987) 3.21
Antibodies to a scrapie prion protein. Nature (1984) 3.09
Identification of prion amyloid filaments in scrapie-infected brain. Cell (1985) 3.04
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol (1997) 2.95
Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell (1993) 2.93
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol (1999) 2.92
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology (1990) 2.90
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev (1992) 2.87
Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature (1999) 2.83
Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A (1996) 2.79
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature (2001) 2.78
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A (1994) 2.70
Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell (1994) 2.68
Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem (1992) 2.67
Chimeric prion protein expression in cultured cells and transgenic mice. Protein Sci (1992) 2.67
Predicted alpha-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci U S A (1992) 2.64
Mapping the prion protein using recombinant antibodies. J Virol (1998) 2.64
Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci U S A (1987) 2.61
Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci (2001) 2.60
Scrapie prion proteins are synthesized in neurons. Am J Pathol (1986) 2.54
Pathologic conformations of prion proteins. Annu Rev Biochem (1998) 2.50
Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci U S A (1999) 2.44
Prion protein gene variation among primates. J Mol Biol (1995) 2.43
Molecular cloning of a human prion protein cDNA. DNA (1986) 2.43
Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol (1990) 2.42
Scrapie PrP 27-30 is a sialoglycoprotein. J Virol (1985) 2.40
Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev (1996) 2.39
Cultured cell sublines highly susceptible to prion infection. J Virol (2000) 2.38
Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc Natl Acad Sci U S A (1994) 2.38
Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A (1994) 2.37
Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem (1988) 2.35
Prion protein selectively binds copper(II) ions. Biochemistry (1998) 2.32
A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol (1997) 2.32
Changes in the localization of brain prion proteins during scrapie infection. Neurology (1987) 2.27
Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry (1980) 2.27
Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment. J Immunol (2001) 2.16
Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14
Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time. Mol Cell Biol (1988) 2.14
Monoclonal antibodies to the cellular and scrapie prion proteins. J Infect Dis (1986) 2.13
Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13
Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A (1996) 2.12
Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol (1991) 2.11
Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet (1989) 2.11
Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Proc Natl Acad Sci U S A (1993) 2.10
Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med (1991) 2.05
Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med (1999) 2.04
Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med (1985) 2.04
Comparative virulence of respiratory syncytial virus subgroups A and B. Lancet (1989) 2.03
Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis (2012) 2.03
Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry (2000) 2.02
Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell (1983) 2.02
Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev (1994) 2.00